14 patients administered bivalent Moderna covid-19 vaccines after 30 day beyond use date; No Adverse Event; 14 patients administered bivalent Moderna covid-19 vaccines after 30 day beyond use date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (14 patients administered bivalent Moderna covid-19 vaccines after 30 day beyond use date), PRODUCT STORAGE ERROR (14 patients administered bivalent Moderna covid-19 vaccines after 30 day beyond use date) and NO ADVERSE EVENT (No Adverse Event) in a 65-year-old patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 021H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 15-Dec-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .5 milliliter. On 15-Dec-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (14 patients administered bivalent Moderna covid-19 vaccines after 30 day beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (14 patients administered bivalent Moderna covid-19 vaccines after 30 day beyond use date) and NO ADVERSE EVENT (No Adverse Event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (14 patients administered bivalent Moderna covid-19 vaccines after 30 day beyond use date), PRODUCT STORAGE ERROR (14 patients administered bivalent Moderna covid-19 vaccines after 30 day beyond use date) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown.        The action taken with mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) was unknown.   For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No Adverse Event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (14 patients administered bivalent Moderna covid-19 vaccines after 30 day beyond use date) and PRODUCT STORAGE ERROR (14 patients administered bivalent Moderna covid-19 vaccines after 30 day beyond use date).    Concomitant product use was not provider by the reporter.  No patients have been administered monovalent vaccine after the beyond use date. Doses were administered from 08-Dec-2022 to 10-Jan-2023. Date the vial was initially stored in the refrigerator is 24-Oct- 2022.  Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2023-704537, US-MODERNATX, INC.-MOD-2023-704551, US-MODERNATX, INC.-MOD-2023-704566, US-MODERNATX, INC.-MOD-2023-704578, US-MODERNATX, INC.-MOD-2023-704595, US-MODERNATX, INC.-MOD-2023-704615, US-MODERNATX, INC.-MOD-2003-704632, US-MODERNATX, INC.-MOD-2023-704639, US-MODERNATX, INC.-MOD-2023-704647, US-MODERNATX, INC.-MOD-2023-704660, US-MODERNATX, INC.-MOD-2023-704665, US-MODERNATX, INC.-MOD-2023-704681, US-MODERNATX, INC.-MOD-2023-704699 (Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 23-Jan-2023: Follow-up received included patient demographics and narrative updated. On 24-Jan-2023: Follow-up received included no new information.; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-704537:2nd adult US-MODERNATX, INC.-MOD-2023-704566:4th adult US-MODERNATX, INC.-MOD-2023-704578:5th adult US-MODERNATX, INC.-MOD-2023-704551:3rd adult US-MODERNATX, INC.-MOD-2023-704615:7th adult US-MODERNATX, INC.-MOD-2023-704665:12th adult US-MODERNATX, INC.-MOD-2023-704639:9th adult US-MODERNATX, INC.-MOD-2023-704681:13th adult US-MODERNATX, INC.-MOD-2023-704699:14th adult US-MODERNATX, INC.-MOD-2023-704660:11th adult US-MODERNATX, INC.-MOD-2003-704632:8th adult US-MODERNATX, INC.-MOD-2023-704647:10th adult US-MODERNATX, INC.-MOD-2023-704595:6th adult